Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push - Reuters

Reuters | Oct. 15, 2025, 9:21 a.m. | Original
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push Reuters
Wall St set for higher open after strong bank earnings, chip stocks rally - Reuters Germany, France sign deal for satellite-based early warning system - Reuters